Xiwei Xu
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology 6
- Clostridium difficile and Clostridium perfringens research 4
- Endocrinology top 10%
- Microbiology top 10%
-
- Pneumonia and Respiratory Infections 3
- Microscopic Colitis 3
-
- Viral Infections and Immunology Research 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Gut microbiota and health 3
- Journals
- Clinical Infectious Diseases (1 paper)Scientific Reports (1 paper)Emerging infectious diseases (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xiwei Xu
22 papers receiving 444 citations
Peers
Comparison fields: 5 of 72
- Molecular Medicine 109
- Infectious Diseases 180
- Endocrinology 49
- Microbiology 42
- Applied Microbiology and Biotechnology 13
Countries citing papers authored by Xiwei Xu
This map shows the geographic impact of Xiwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwei Xu more than expected).
Fields of papers citing papers by Xiwei Xu
This network shows the impact of papers produced by Xiwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwei Xu. The network helps show where Xiwei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiwei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2019 | 1 | |
| 3 | 2019 | 5 | |
| 4 | [Virulence genes and clinical features of Clostridium difficile-associated diarrhea in children]. | 2015 | 2 |
| 5 | 2014 | 143 | |
| 6 | 2013 | 10 | |
| 7 | [Risk factors of Clostridium difficile-associated diarrhea in children]. | 2012 | 4 |
| 8 | Survey of Helicobacter pylori Infection Among Children with Alimentary Tract Discomforts in Beijing Area | 2011 | 1 |
| 9 | 2010 | 2 | |
| 10 | 2010 | 22 | |
| 11 | 2010 | 68 | |
| 12 | 2010 | 16 | |
| 13 | [Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella spp. isolated in children]. | 2010 | 4 |
| 14 | 2009 | 34 | |
| 15 | 2009 | 3 | |
| 16 | 2008 | 83 | |
| 17 | 2008 | 41 | |
| 18 | [Transfer of erythromycin-resistance among strains and species of bacteria: plasmid conjugation method in enterococcal isolates]. | 2007 | 3 |
| 19 | Codon Optimization and Expression of Norovirus Capsid Proteins in Insect Cells | 2006 | 3 |
| 20 | Development of a TaqMan--based Real--time reverse transcription PCR for detecting genogroup II norovirus in clinical stool samples | 2006 | 1 |
About Xiwei Xu
Xiwei Xu is a scholar working on Molecular Medicine, Endocrinology and Infectious Diseases, having authored 22 papers that have together received 453 indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (6 papers), Antibiotic Resistance in Bacteria (6 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Pneumonia and Respiratory Infections (3 papers), Viral Infections and Immunology Research (3 papers), Microscopic Colitis (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Molecular Medicine (109 citations), Infectious Diseases (180 citations) and Endocrinology (49 citations). Xiwei Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Shu Guo, Yonghong Yang, Chuanqing Wang, Yuan Li, Yuezhu Wang, Xia Liu, Zongxin Ling, Yiwen Cheng, Lanjuan Li and Charlie Xiang. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.